Non-Opioid Pain Patches Market
Global Non-Opioid Pain Patches Market Size, Share & Trend Analysis Report by Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, and Ketoprofen Patches), By Distribution Channels (Hospitals Pharmacies, Online Pharmacies, and Drug and Medical Stores), Forecast (2022-2028) Update Available - Forecast 2024-2030
The global non-opioid pain patches market is anticipated to grow at a significant CAGR of around 4.5% during the forecast (2022-2028). Non-opioid pain patches are used for the treatment of patients suffering from chronic pain. One of the major factors for the growth of the global non-opioid pain patches market is the increasing number of patients suffering from neuropathic pain and cancer. The causes for neuropathic pain include injury or malfunction in the central or peripheral nervous system. Furthermore, the rising number of patients with spinal cord injuries and diabetes add some other major causes for neuropathic pain. A patient may feel pain numbness and weakness in hands or feet due to diabetic neuropathy. Due to side effects of opioid medication such as addiction, the demand for nonopioid pain patches including lidocaine patches increased. Lidocaine patch is a sodium channel blocker used for the treatment of neuropathic pain by stopping nerves from transmitting pain signals. Thus, an increase in demand for lidocaine patches propelled the growth of the global non-opioid pain patches market.
Impact of COVID-19 on Global Non-opioid pain patches Market
COVID-19 has impacted the global economy due to a slowdown in the manufacturing of various industries. Healthcare came under the essential services so the manufacturing of non-opioid pain patches was persistent throughout the pandemic. The distribution and demand for non-opioid pain patches were regular as the number of surgeries in hospitals was increasing.
Segmental Outlook
The global non-opioid pain patches market is segmented based on type and distribution channels. Based on type, the market is sub-segmented into lidocaine patches, diclofenac patches, capsaicin patches, and ketoprofen patches. Based on the distribution channel, the market is sub-segmented into hospital pharmacies, online pharmacies, and drug and medical stores. Among these, the lidocaine type segment is expected to hold a prominent share in the global non-opioid pain patches market due to the increasing number of patients complaining about neuropathic pain.
Global Non-Opioid Pain Patches Market by Distribution Channel, 2021(%)
The Hospital Pharmacies Segment is Anticipated to Hold a Major Share in the Global Non-opioid pain patches market.
The hospital pharmacies segment is expected to hold the major share in the global non-opioid pain patches market during the forecast year due to the increasing number of surgeries performed in the hospital. The non-opioid pain patches are used during and after the surgery to reduce the level of pain. Hospitals performing a significant number of surgeries every year demand these non-opioid pain patches, which majorly come from hospital pharmacies. Contributing to the application of non-opioid pain patches from hospital pharmacies.
Regional Outlooks
The global non-opioid pain patches market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The North American region is expected to hold the major share in the global non-opioid pain patches market due to the increasing number of patients suffering from chronic pain in the region.
Global Non-opioid pain patches Market Growth by Region, 2022-2028
The Asia Pacific Region is Expected to Grow at a Significant CAGR among the Global Non-opioid pain patches Market During Forecast Year.
The Asia Pacific regional non-opioid pain patches market is anticipated to grow at a significant CAGR during the forecast year due to the presence of a large old-age population suffering from chronic pain in joints. Due to pain, they have to go through joint and knee replacements surgeries increasing the demand for non-opioid pain patches for the reduction of pain during and post-surgery. According to a post published in The Jakarta Post in October 2021, the population of people aged over 60 is rapidly growing in the Asia Pacific region. It is expected to reach 1.3 billion senior citizens by 2050. Furthermore, the old-age population also has to deal with postherpetic neuralgia, diabetic neuropathy, and low back pain increases the demand for no-opioid pain patches growing the Asia Pacific non-opioid pain patches market.
Market Players Outlook
The major companies serving the global non-opioid pain patches market include Acorda Therapeutics, Inc., Endo International plc, Hisamatsu Pharmaceuticals Co. Inc., Sanofi S.A., Sorrento Therapeutics, Inc., and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, fundings, and new product launches. For instance, in March 2019, Sorrento Therapeutics Inc. (Scilex Pharmaceuticals Inc.) merged with Semnur Pharmaceuticals, Inc. to form a new company, Scilex Holding Co... The company got a lead compound of Semnur Pharmaceuticals Inc., a non-opioid corticosteroid gel. This compound was in phase 3 pivotal studies for the treatment of lumbar radicular pain and sciatica with fast-track status from FDA benefiting the Scilex Holding co. to gain prominent share in non-opioid pain mgt.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global non-opioid pain patches market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Non-Opioid Pain Patches Market
- Recovery Scenario of Global Non-Opioid Pain Patches Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Acorda Therapeutics, Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Endo International plc
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Hisamitsu Pharmaceuticals Co. Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Sanofi S.A.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Sorrento Therapeutics, Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Non-Opioid Pain Patches Market by Type
4.1.1. Lidocaine Patch
4.1.2. Diclofenac Patch
4.1.3. Capsaicin Patch
4.1.4. Ketoprofen Patch
4.2. Global Non-Opioid Pain Patches Market by Distribution Channel
4.2.1. Hospitals Pharmacies
4.2.2. Online Pharmacies
4.2.3. Drug and Medical Stores
5. Regional Analysis
5.1. North America
5.1.1. The US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abbott
6.2. AstraZeneca group Co.
6.3. Baxter International, Inc.
6.4. Cadila Healthcare Ltd. (CHL)
6.5. Cardinal Health, Inc.
6.6. Eli Lilly and Co.
6.7. Merck Group
6.8. Novartis International AG
6.9. Pfizer Inc.
6.10. Teikoku Seiyaku Co. Ltd.
6.11. Teva Pharmaceuticals Industries Ltd.
6.12. Thermo Fisher scientific Inc.
6.13. Veridian Healthcare
6.14. Virpax Pharmaceuticals
1. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL LIDOCAINE NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL DICLOFENAC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL CAPSAICIN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL KETOPROFEN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
7. GLOBAL NON-OPIOID PAIN PATCHES IN HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL NON-OPIOID PAIN PATCHES IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL NON-OPIOID PAIN PATCHES IN DRUG AND MEDICAL STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
13. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL FORM, 2021-2028 ($ MILLION)
14. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL FORM, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL FORM, 2021-2028 ($ MILLION)
20. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
22. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL FORM, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL NON-OPIOID PAIN PATCHES MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL NON-OPIOID PAIN PATCHES MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL NON-OPIOID PAIN PATCHES MARKET, 2021-2028 (%)
4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL LIDOCAINE NON-OPIOID PAIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL DICLOFENAC NON-OPIOID PAIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL CAPSAICIN NON-OPIOID PAIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL KETOPROFEN NON-OPIOID PAIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.
10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY DISTRIBUTION CHANNEL FORM, 2021 VS 2028 (%)
11. GLOBAL NON-OPIOID PAIN PATCHES IN HOSPITAL PHARMACIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL NON-OPIOID PAIN PATCHES IN ONLINE PHARMACIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL NON-OPIOID PAIN PATCHES IN DRUG AND MEDICAL STORES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. US NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
17. UK NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
19. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
24. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
26. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
